UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057604
Receipt number R000065816
Scientific Title Investigation of Acquired von Willebrand Syndrome caused by Mechanical Circulatory Support Devices
Date of disclosure of the study information 2025/05/01
Last modified on 2025/05/02 03:50:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of Acquired von Willebrand Syndrome caused by Mechanical Circulatory Support Devices

Acronym

AvWS-MCS Study

Scientific Title

Investigation of Acquired von Willebrand Syndrome caused by Mechanical Circulatory Support Devices

Scientific Title:Acronym

Investigation of Acquired von Willebrand Syndrome caused by Mechanical Circulatory Support Devices

Region

Japan


Condition

Condition

Healthy adult volunteers

Classification by specialty

Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assessment of the severity of acquired von Willebrand syndrome induced by ECMO and Impella, and evaluation of the therapeutic effects of von Willebrand factor concentrate

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

von Willebrand factor antigen level, ristocetin cofactor activity (RCo), large multimer index (LMI), and platelet aggregation function assessed by total thrombus-formation analysis system (t-TAS)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Age 18 years or older
Body weight more than 45 kg for males and more than 40 kg for females
Able to provide written informed consent voluntarily

Key exclusion criteria

Individuals with chronic conditions requiring regular outpatient visits
Individuals taking prescribed medications on a regular basis
Individuals with a known hematologic disorder
Individuals who have ever been noted to have anemia, either during a hospital visit or health screening
Individuals who have participated in this study within the past four weeks
Individuals who are pregnant or may be pregnant
Individuals deemed unsuitable for participation as healthy volunteers by the principal investigator

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Mariko
Middle name
Last name Hayamizu

Organization

Hokkaido University Hospital

Division name

Department of Emergency Medicine

Zip code

060-8648

Address

N14W5 Kita-ku, Sapporo 060-8648, Japan

TEL

011-706-7377

Email

hayamizuma@gmail.com


Public contact

Name of contact person

1st name Mariko
Middle name
Last name Hayamizu

Organization

Hokkaido University Hospital

Division name

Department of Emergency Medicine

Zip code

060-8648

Address

N14W5 Kita-ku, Sapporo 060-8648, Japan

TEL

011-706-7377

Homepage URL


Email

hayamizuma@gmail.com


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital

Address

N14W5 Kita-ku, Sapporo 060-8648, Japan

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 09 Day

Date of IRB


Anticipated trial start date

2025 Year 06 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To investigate the impact of mechanical circulatory support devices on von Willebrand factor (vWF), we will conduct in vitro experiments using blood obtained from healthy volunteers. The collected blood will be circulated through a mock extracorporeal membrane oxygenation (ECMO) circuit, and vWF degradation resulting from centrifugal pump operation will be evaluated. A parallel set of experiments will be performed using the Impella device to assess its specific effects on vWF. Upon elucidating the extent and nature of vWF alterations induced by ECMO and Impella, we will examine the potential for vWF concentrate supplementation to restore vWF levels. Furthermore, we will compare the efficacy of different administration strategies, including single bolus and continuous infusion, in mitigating device-induced vWF depletion.


Management information

Registered date

2025 Year 04 Month 14 Day

Last modified on

2025 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065816